• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • All Drug Products
  • Diseases & Conditions
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Therapy Areas
  • Neuroscience
  • RECONNECT-S ALPHA: A Non-interventional Study to Observe Real-life Allocation of Antipsychotics in the Acute Inpatient Management of Schizophrenia

Disease
schizophrenia
Drug Name
non drug study (neuroscience)
Sponsor
AstraZeneca
Drug Status
Non-Drug
Phase
Non-Interventional Study
Start Date
Jan 18, 1971
Study Name
RECONNECT-S
Study Id
NIS-NRU-ATC-2011/1
ClinicalTrials.gov ID
NCT01394601
Recruiting Status
Closed
Protocol Status
Not Available
Report
Nov 16, 2012
  • NIS-NRU-ATC-2011/1.pdf (455 KB)

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2013